Previous Article | Next Article ![]()
Infection and Immunity, September 2001, p. 5874-5882, Vol. 69, No. 9
Laboratoire d'Immunopathologie Cellulaire
des Maladies Infectieuses, UMR 8527,1 and
Laboratoire de Synthèse, Structure, et Fonction des
Biomolécules, UMR 8525,2 Institut de
Biologie, F-59021 Lille, France
Received 14 November 2000/Returned for modification 4 January
2001/Accepted 18 May 2001
Genetic factors that might influence susceptibility or resistance
in naive individuals and early-stage pathology in schistosomiasis are
difficult to study in clinical trials, since in areas where the disease
is endemic the first contact with the parasite occurs most often at
very early ages. Therefore, four strains (DR1.A Several associations between various
pathologies and specific HLA antigens have been reported
(36). However, the role of HLA polymorphism in infectious
diseases has not yet been fully explored. Presently, the only valuable
association, to our knowledge, between an infectious disease and HLA
class II molecules is that of tuberculoid leprosy with
HLA-DRA/B1*0301 (25).
In schistosomiasis, it is difficult to estimate the development of
acquired resistance to reinfection, which is age and sex related
(31) but also depends on daily exposure to the parasite. Recently, a genomic region involved in resistance has been described (21, 22). This locus is positioned on chromosome 5q31-q33, a region encoding several candidate genes involved in the regulation of
the immune response to pathogens, namely, colony-stimulating factor-1
receptor, interleukin-3 (IL-3), IL-4, IL-5, and IL-13 (5,
33).
Most of the epidemiological studies focused on the factors involved in
progression of fibrosis and development of severe hepatic disease.
Lethal disease is a consequence of portal hypertension, which
progressively leads to hematemesis and heart failure. In its early
stage, fibrosis is part of the healing process that follows the acute
inflammatory reaction around parasite eggs trapped in presinusoidal
venules. Chronical hepatosplenomegaly is a consequence of extended
fibrosis in the hepatoportal spaces. Severe hepatoportal disease was
noted in certain families, while others living in the same
environmental and hygienic conditions were less affected (10). The group of Salam et al. (32) was the
first to describe a linkage between progression toward
hepatosplenomegaly and HLA class I antigens. A study of an Egyptian
population (15) showed a negative association of DR2 with
severe disease. Secor et al. (34), in a study on Brazilian
patients, could not confirm this finding, but showed that
HLA-DQB1*0201 was associated with an increased risk in developing
severe hepatosplenic forms of disease. Unfortunately, the HLA-DQB1
frequencies in healthy populations were not evaluated.
In areas where the parasite is endemic, the first contact with the
parasite occurs most often at very early ages, and little is known
about genetic factors involved in the induction of protective response.
In the initial stages of infection in mice, granulomas have a
protective role against the diffusion of toxins released by the
parasite eggs. This was shown in SCID, nude, or T-cell-depleted mice,
which are unable to develop granulomas and die as a consequence of
hepatocellular necrosis (2, 11, 28). Egg-induced
granulomas have been characterized as a CD4+
T-cell-mediated delayed-type hypersensitivity response (23, 37). In mice, the early stage of Schistosoma mansoni
infection is dominated by a type 1 response, which is then
progressively replaced, from the onset off egg laying, by a type 2 response that becomes maximal at 8 weeks of infection
(27).
Whereas the influence exerted by CD4+ T cells has been well
studied, little is known about the impact of the HLA polymorphism on
the early stage of the immune response induced against S. mansoni. In order to tackle this problem, we took advantage of the
facts that in mice this parasite can fully develop and that this
experimental model is currently used to explore cellular mechanisms
involved in the granulomatous reaction. Therefore, HLA transgenic mice expressing different HLA alleles (36) were chosen. These
mice were generated or backcrossed on an A Mice.
Mice used in this study (Table
1) were bred and maintained in
pathogen-free conditions in the animal unit of the Pasteur Institute of
Lille (France). Mice expressing different HLA alleles (HLA-DR2,-DQ6,
and -DQ8) and deficient in murine class II molecules (HLA.A
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.9.5874-5882.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
HLA Class II Polymorphism Influences Onset and
Severity of Pathology in Schistosoma mansoni-Infected
Transgenic Mice
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
°, DR2.A
°,
DQ8.A
°, and DQ6.A
°) of major histocompatibility complex class
II-deficient mice (A
°), transgenic for different HLA alleles, have
been used to evaluate the potential role of HLA class II polymorphism
in the onset of the infection by Schistosoma mansoni. The
survival rates and parasitological and immunological parameters after
infection were evaluated and compared against the control values
obtained with A
° mice. All four mouse strains used in this study
were able to generate a specific immune response against S. mansoni antigens (cytokine production and antibody production). However, only mice expressing DR alleles survived until the chronic stage of the infection and were able to mount protective granulomatous response avoiding hepatic damage, presenting predominant gamma interferon production. In contrast, strains expressing DQ alleles revealed an impairment in generating effective granulomas, resulting in
earlier death, which was associated with an impaired hepatic granulomatous response and liquefactic necrosis, reflecting the influence of HLA polymorphism in the establishment of protective response in the early stage of infection.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
° background (i.e.,
deficient for murine major histocompatibility complex [MHC] class II
molecules) (8). As a consequence of the absence of
endogenous murine MHC class II molecules, the class II response is
restricted to the HLA transgene, allowing the contribution of each of
the HLA alleles to be assessed independently. This is of special
interest since several HLA-DR and -DQ molecules are cross-linked,
enhancing the difficulty in evaluating the specific role of each. It
has to be stressed that the pool of CD4+ T cells is
reconstituted in HLA.A
° transgenic mice due to thymic selection
restricted to the transgene (36). This model was shown to
be valuable in the study of several autoimmune pathologies such as
collagen-induced arthritis (4, 14), experimental encephalitis (1, 16), autoimmune thyroiditis
(17), and in "Der p" (extract of
Dermatophagoides pteronyssinus)-induced allergy
(24). In our study, we used four strains of mice
expressing HLA class II molecules: two DR (DR1 and DR2) and two DQ (DQ6
and DQ8) strains. Survival rates, liver histology, and parasitological and immunological parameters were evaluated after S. mansoni
infection, in comparison to nontransgenic A
° mice. We discuss the
diversity of responses obtained in these different strains as a
consequence of HLA polymorphism.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
°) were
a kind gift from C. David (Mayo Clinic, Rochester, Minn.)
(36). Mice expressing HLA-DR1 transgene on an FVB/N
background were kindly provided by D. Altmann (1). To
eliminate murine endogenous MHC class II molecules, DR1 mice were
backcrossed with A
° mice for two generations. Thus, in the case of
DR1.A
° mice the influence of the mixed background on parasitic and
immune parameters cannot be excluded. Prior to experimentations,
CD4+ T-cell levels in DR1.A
° were verified: 33.4% of
cells present in lymph nodes expressed CD4+ (compared to
41.6% in DR1/FVB mice), while 16.1% of splenic cells were
CD4+ (compared to 27.55% in DR1/FVB mice). A
° mice
were provided by D. Mathis and C. Benoist (LGME/CNRS, Strasbourg,
France) (8), and immunologically intact C57BL/6 mice were
purchased from Iffa Credo (l'Arbesle, France). Five- to seven-week-old
mice were used in our experiments.
TABLE 1.
HLA-transgenic mice used in this study, with references
characterizing the strains indicated
Parasite life cycle. A Puerto Rican strain of S. mansoni was maintained in Biomphalaria glabrata snails as intermediate hosts and in Mesocricetus auratus golden hamsters as definitive hosts. Cercariae for experimental infections were used within 1 h of collection and enumeration, from 1-month-infected snails exposed to light and to a temperature of 30°C for 1 h.
Infection Protocol. Mice were infected percutaneously by exposing the abdominal skin to 50 cercariae of S. mansoni as previously described (35).
Sera were collected by retro-orbital bleeding 24 h before infection (day 0) and 14, 28, and 42 days after infection and stored at
80°C for immunoglobulin and cytokine quantifications. At 42 days
after infection, the parasite burden was evaluated by total perfusion.
Following perfusion, the liver was recovered and the parasite eggs
retained in the tissue were counted, after an alkaline digestion with a
4% KOH solution for 24 h at 37°C. Results are expressed as the
mean number of eggs/worm pair/gram of liver ± the standard deviation.
Prior to KOH digestion, one hepatic lobe was removed, fixed in Bouin
liquor (saturated solution of picric acid-formaldehyde-acetic acid,
15:2:1 [vol/vol/vol]) and used for histological analysis.
Parasite antigen preparations.
Schistosomulum antigen (SOM)
was prepared by sonication of frozen-thawed mechanically prepared
schistosomula (30) and centrifuged for 20 min at
10,000 × g. Soluble worm antigenic product (SWAP) was
prepared by homogenizing adult worms by a 5-min sonication (Labsonic U,
B. Braun, Templemars, France) and centrifuged for 20 min at
10,000 × g. Schistosome egg antigen (SEA) was prepared from homogenized eggs isolated from livers of 40-day S. mansoni-infected hamsters. Frozen eggs were disrupted by eight
passages through an X-press (A. B. Biot, Jarfalla, Sweden), and
the soluble fraction was collected after centrifugation for 15 min at
10,000 × g. The antigenic preparations were filtered
through a 0.22-µm (pore-size) membrane (Millipore, Bedford, Mass.)
and stored at
20°C until use. Protein concentrations were
determined using the BCA Protein Assay Reagent (Pierce, Rockford,
Ill.).
Histological study. Liver sections (6 µm thick), prepared from paraffin-embedded samples, were stained using Masson Trichrome stain (Sigma Chemical Co, St. Louis, Mo.) and then examined using a Leitz Diaplan microscope (Wild Leitz, Rueil-Malmaison, France).
To measure collagen deposition, the colorimetric method described by Lopez de-Leon et al. (18) was employed. Liver sections 10 µm thick were placed on slides, deparaffinized, and incubated with a saturated solution of picric acid in distilled water, containing 0.1% fast green FCF (Sigma) which stains noncollagenous proteins, and 0.1% sirius red F3B (Gurr BDH Chemicals, Ltd., Poole, United Kingdom) staining specifically collagen. Sections were kept in the dark and incubated at room temperature for 2 h under agitation. They were then rinsed with distilled water, and the retained stain was eluted from the section using 1 ml of 0.1 N NaOH in absolute methanol (1:1 [vol/vol]). Fluids were carefully withdrawn, and the absorbance was measured at 540 nm (maximal absorbance of sirius red) and 620 nm (maximal absorbance of fast green) by using a multichannel spectrophotometer (Titertek Multiskan MCC/340; Labsystem, Helsinki, Finland). For each individual, three consecutive sections of the liver were used. The amount of collagen deposition in hepatic tissue was calculated using the formula described previously (18). Data were expressed as micrograms of collagen/milligrams of noncollagenous proteins.In vitro stimulation assay.
Spleens from infected mice or
healthy controls were removed aseptically 42 days after infection.
Cells were cultured in 24-well plates (Nune, Intermed S.A., Roskilde,
Denmark) in 1 ml per well of cell culture medium (ML-10) consisting of
RPMI 1640 (Gibco, Courbevoie, France) supplemented with 50 µM
-mercaptoethanol (Merck, Darmstadt, Germany), 2 mM
L-glutamine (Merck), 1 mM sodium pyruvate (Gibco), 10%
heat-inactivated fetal calf serum (Gibco), and 50 µg of gentamicin
(Gibco) per ml at 37°C in a 5% CO2 atmosphere. Cells
(2 × 106 cells/ml) were specifically stimulated with
50 µg of SEA per ml. Mitogenic stimulation with concanavalin A (5 µg/ml) was used as positive control. At 48 h after antigenic
stimulation, cell culture supernatants were harvested and tested for
cytokine release.
Cytokine quantification.
Using the enzyme-linked
immunosorbent assay (ELISA) method, gamma interferon (IFN-
) and IL-4
production were evaluated in sera or in culture supernatants of in
vitro-stimulated splenic cells. Briefly, Maxisorp plates (Nunc) were
coated overnight at 4°C with 0.05 µg of purified rat anti-mouse
monoclonal antibody (MAb) R4-6A2 (for IFN-
) or 11B11 (for IL-4)
(PharMingen, San Diego, Calif.) per well, respectively, diluted in 0.1 M sodium carbonate-bicarbonate buffer (pH 8.6). After a washing with
phosphate-buffered saline (PBS; 0.15 M NaCl, 10 mM PBS; pH 7.2)-0.1%
Tween 20 (T-PBS), a blocking step was performed using 100 µl of a 3%
bovine serum albumin (BSA; Sigma) solution in PBS for 2 h at room
temperature (RT). After additional washings, sera or supernatants were
added and incubated overnight at 4°C. Sera were tested at 1:10 to
1:20 dilutions, while cell culture supernatants were used in serial dilutions of from 1:1 to 1:8 dilution in PBS-3% BSA. After the washing, 100 µl of 1-µg/ml dilution of the biotinylated rat
anti-mouse MAb XMG1-2 (IFN-
) or BVD6-24G2 (IL-4) (PharMingen) per
well, respectively, were added for 1 h at RT. After a renewed
washing, peroxidase-labeled streptavidin conjugate (PharMingen) was
added at a 1:10,000 dilution in PBS for 30 min at RT. After three
washes with T-PBS, plates were incubated with 100 µl of
o-phenylenediamine dihydrochloride substrate (Sigma) at 1 mg/ml diluted in sodium phosphate-citrate buffer (0.1 mM, pH 5.5)
containing 0.03% H2O2 for 10 min at RT. The
reaction was stopped by the addition of 50 µl of HCl at 1 N per well.
The absorbance at 492 nm was measured using a multichannel
spectrophotometer (Labsystem). The results are expressed as the mean
absorbance values of duplicate wells after subtraction of the
background. Samples were tested individually, and the results are
expressed as the mean ± the standard deviation.
Specific antibody quantification. Detection of specific antibodies in sera was performed by ELISA on Maxisorp plates, coated overnight at 4°C with 50 µl of a 15-µg/ml solution of the parasite antigens SOM, SWAP, or SEA diluted in sodium carbonate buffer per well. After a washing with T-PBS and a blocking step, 100 µl of mouse serum in PBS-3% BSA buffer was incubated overnight at 4°C. After additional washes, 100 µl of peroxidase-labeled anti-mouse IgG(H+L) (Sanofi Diagnostics Pasteur, Marnes-la-Coquette, France) diluted 1:10,000 in the same buffer was added for 1 h at RT, followed by washing and o-phenylenediamine substrate addition under the same conditions mentioned above for the cytokine quantification.
Statistics. Statistical significance was determined by using Student's t test, with P values of <0.05.
| |
RESULTS |
|---|
|
|
|---|
Mortality and liver pathology in HLA.A
° infected mice.
As
shown in Fig. 1, DR1.A
° and
DR2.A
° mice survived more than 90 days after infection with 50 cercariae of S. mansoni, whereas the survival of the
DQ6.A
° and of the A
° control mice was limited to ca. 50 days
postinfection (p.i.). Mortality in DQ8.A
° mice at 50 days p.i. was
slightly lower than in A
° mice but significantly higher than in
DR1.A
° and DR2.A
° mice.
|
° mice. As already described
(3), Masson's trichrome staining showed lack of
granulomatous reaction in A
° mice (Fig. 2A), with few cellular
aggregates around certain eggs without collagen deposition. The absence
of a granulomatous reaction was associated with a profound hepatic
damage in the vicinity of the parasite eggs, indicating a hepatotoxic
effect. DR1.A
° and DR2.A
° mice were able to mount efficient
granulomatous reactions (Fig. 2C and D). DQ6.A
° mice showed the
same histological pattern as A
° mice (Fig. 2E), whereas
DQ8.A
° mice presented a cellular reaction devoid of any tissular
damage (Fig. 2F). Quantification of collagen content in the liver at 42 days p.i. showed that both DR1.A
° and DR2.A
° mice displayed
collagen deposition unlike DQ8.A
° mice (Fig.
3), thus being concordant with the
histological aspect. However, in both DR-expressing mice, collagen
deposition is somewhat lower than in immunologically intact C57BL/6
mice. Unfortunately, due to the severe hepatic damage, this study was not feasible in DQ6.A
° mice.
|
|
° and DR2.A
° strains that mounted protective granulomatous responses, to the DQ6.A
° and A
° mice that died rapidly, while DQ8.A
° presented intermediate survival and
granulomatous reactions.
Parasite burden in HLA.A
° infected mice.
At 42 days p.i.,
the adult worm burden was assessed by blood perfusion (Fig.
4A), and the numbers of parasite
eggs/worm pair were counted in the liver (Fig. 4B). No significant
difference in parasite burden among the different transgenic and
A
° mice strains could be seen. Similarly, no significant
differences were observed in the numbers of parasite eggs trapped in
the liver, except between the DQ8.A
° strain and the control mice
(P value of Student's t test = 0.0239).
|
Cellular response to parasite antigens.
Levels of IFN-
and
IL-4 were determined in sera 42 days p.i. As shown in Fig.
5, transgenic mice were able to produce
IFN-
, IL-4, or both cytokines, unlike the A
° mice. DR2.A
°
and DQ6.A
° mice produced both cytokines. However, only 18% of
DQ6.A
° produced IFN-
, while 72% DR2.A
° mice produced this
cytokine. In addition, the concentrations of IFN-
in DQ6.A
°
were significantly lower than in DR2.A
° mice sera (P = 0.026). The proportion of mice producing IL-4 in DQ6.A
° mice
was 65% compared to 56% of DR2.A
°, but the amounts of IL-4
detected in DQ6.A
° mice were significantly lower than those found
in DR2.A
° mouse sera (P < 0.01). Fifty-eight percent of the DR1.A
° mice secreted IFN-
in amounts comparable to the DR2.A
° mice but were unable to secrete detectable levels of
IL-4. In contrast, DQ8.A
° mice, unable to systemically produce IFN-
, secreted low but detectable levels of IL-4, with 23% of the
sera tested being positive for IL-4.
|
° mice were not able to
respond (3), whereas transgenic mice cells produced both
cytokines when stimulated with SEA (Table
2). In all transgenic strains, the
production of IFN-
was predominant, the IL-4 levels being relatively
low. DR2.A
° mice secreted the highest amounts of both cytokines,
DR1.A
° and DQ6.A
° mice produced significant, but intermediate
quantities, while DQ8.A
° mice produced the lowest level. It can be
thus concluded that all of the transgenes tested were capable of
presenting antigenic fragments to CD4+ murine T cells.
|
Humoral response to parasite antigens.
A
° mice are unable
to generate antibodies against thymodependent antigens (8,
20). In order to verify the effectiveness of T-B cellular
cooperation in HLA transgenic strains, specific IgG antibodies to SOM,
SWAP, and SEA antigens were analyzed. As shown in Fig.
6, all of the transgenic strains were
able to produce antibodies against the three antigens tested, similar
to the findings with immunocompetent mice (data not shown).
Nevertheless, some variations in the amounts of specific antibodies to
SOM (A) and SWAP (B) were observed among the strains, with DR2.A
°
mice producing the highest and DQ6.A
° mice producing the lowest
concentrations.
|
| |
DISCUSSION |
|---|
|
|
|---|
Among the parameters we studied, the first finding was the
striking difference in mortality, according to the expressed transgene. Indeed, only DR-expressing mice (DR1.A
° and DR2.A
°) survived until the chronic stage. Additionally, preliminary results in DR3.A
° mice show similar trends (data not shown). In contrast, DQ6.A
° mice have the same mortality profile as the A
° mice. Thus, it seems that the expression of the sole DQ6 allele is unable to
confer protection to the initial stage of infection. DQ8.A
° transgenic mice survived longer than the A
° mice, but survival was
significantly shorter than with the DR-expressing mice. To further
determine the origin of this variability, parasitic parameters were
evaluated at 42 days p.i. corresponding to the onset of parasite egg
laying. No difference could be detected in the parasite burdens among
the strains, suggesting that parasites may develop equally well in all
of them. In general, worm fecundity in transgenic mice was similar to
that in A
° mice, with the sole exception of the DQ8.A
° mice,
which presented a significantly higher egg count than the other
HLA.A
° strains.
As previously reported (3), mortality in A
° mice is
due to hepatotoxic lysis induced by the parasite eggs in the absence of
granulomatous reaction. DR1.A
° and DR2.A
° mice are able to mount typical granulomas comparable to the responses of immunocompetent mice. These reactions seem to be effective, since the surrounding hepatic tissue appears intact. On the contrary, DQ6.A
° mice
present a lack of granulomatous response accompanied by diffuse
hepatocytolysis, like that observed in A
° mice. The DQ8.A
°
strain shows a limited cellular reaction around parasite eggs that is
nevertheless sufficient to protect the hepatic tissue against egg
toxins. Collagen deposition measured by the method of Lopez-de Leon et
al. (18) was in accord with the histological aspects,
showing a lack of collagen deposition in DQ8.A
° mice, unlike the
DR-expressing mice. Thus, we shown that the variability in mortalities
of the various transgenic strains is strongly linked to the intensity
of the granulomatous reaction. In the case of DQ8.A
° mice, with
hepatic tissue appearing unaffected at 42 days p.i., mortality could be
related to a higher egg count. Nevertheless, the incomplete
granulomatous reaction around deposited eggs might also contribute to
the fatal outcome.
Since the early granulomatous reaction is mainly CD4+
dependent and thus MHC class II restricted, we wanted to investigate whether the revealed differences in pathology are related to the capacity to mount specific class II-restricted responses. While A
°
mice are unable to produce cytokines against parasitic antigens, the
cellular response is reconstituted in all tested HLA-A
° strains. Moreover, the in vitro proliferation of splenic cells restimulated with
SEA was similar in the four strains (data not shown). Some variations
in the amount of the produced cytokines are evident and could explain
the differences in the intensity of the granulomatous reaction.
DR2.A
° mice were the most potent in producing cytokines systemically and after in vitro restimulation. Interestingly, DR1.A
° mice produced only IFN-
(and no IL-4) in sera, but they secreted this cytokine when splenic cells were restimulated in vitro.
This suggests that during infection IL-4 is probably produced locally.
DQ6.A
° mice produced both cytokines, though at lower levels than
DR-expressing mice. In general, DQ8.A
° mice produced very low
amounts of either cytokine, with values being close to the cutoff
value. IL-10 detection yielded negative results with all of the
transgenic strains mice (data not shown).
However, a certain influence of a mixed background in DR1.A
° mice
on parasitic and immune parameters cannot be excluded, in our study.
However, compared to DR2.A
° mice (on an
H-2b background), the response appears
qualitatively close, suggesting that in our model the influence of the
genetic background on the outcome of the pathology is of low
importance. In this sense, it should be noted that DQ6.A
° and
DQ8.A
° mice with the same background as the DR2.A
° mice,
reveal striking differences during infection, which are more important
than those between the two DR-allele-expressing mice (DR1 and DR2).
Therefore, in this study we concluded that the differences we observed
are mainly due to the transgene expressed. Backcrossing DR1.A
°
mice until the genetic background becomes similar to the other
transgenic mice would certainly strengthen our results but would
probably not change the information obtained.
The observed quantitative and qualitative variations might also be a
consequence of differences in the expression of the transgenes or due
to thymic selection of a preferential T-cell-receptor repertoire. Thus,
in the DQ6.A
° strain, the interspecific interaction between the
DQ6 transgene and the corresponding murine CD4 receptor is effective
but not efficient in the protection against the parasite S. mansoni. This finding notwithstanding, the DQ6.A
° strain was shown to be functional in other experimental models, such as rheumatoid arthritis (4), recognition of human pre-pro-insulin
peptides (29), and allergy (6).
The profile of cytokine secretion by transgenic mice is also a
parameter to consider. Previous studies in mice showed a protective role for IFN-
in reducing fibrosis at the chronic stage (9, 19, 26). A recent epidemiological study in Sudan revealed an
association between resistance to severe hepatosplenic disease and a
genomic region located on 6q22 to 6q23, coding for IFN-
receptor 1 (10). In our study, we found a predominant IFN-
production in all strains, but the most effective were
DR-allele-expressing mice, which also mounted an efficient
granulomatous response. In general, IL-4 production is low: DR2.A
°
mice secrete the highest levels among the transgenic strains,
representing about 50% of the levels secreted by immunocompetent
C57BL/6 mice.
Strikingly, DR1.A
° mice were unable to produce detectable amounts
of IL-4 in the sera but generated granulomas. In contrast, DQ6.A
°
mice, producing low levels of both cytokines in sera and with an IL-4
level in supernatants comparable to that of DR1.A
° mice, showed an
impaired cellular reaction. It is thus tempting to conclude that in the
initial stage, IFN-
is necessary for an efficient granulomatous
response, whereas IL-4 seems to be less important. Recently, Fallon et
al. (12), using IL-13-deficient mice, showed that IL-13
has a profibrotic effect during the chronic stage of infection. It
would therefore be interesting to evaluate in our transgenic model the
production of this cytokine. However, it is difficult to establish any
direct correlation between the intensity of cellular reaction and the
levels of produced cytokines. For example, DQ8.A
° mice produced
fewer cytokines than DQ6.A
° mice but survived slightly longer. The
mechanisms involved in generating a granulomatous response are complex
and cannot be reduced exclusively to the class II-restricted response.
Other fibrogenic factors could also be implicated, such as tumor
necrosis factor alpha (2). However, in general it seems
that high levels of IFN-
are linked to efficient granulomas, while
low amounts indicate an inability to induce granulomas.
All transgenic strains are, unlike A
° mice, able to generate
specific antibodies against all of the three parasite stages (3). The variation in quantity of antibodies among the
transgenic strains against SOM and SWAP might be a consequence of the
diversity in the repertoire of CD4+ T cells selected by
each transgene. This may influence the B-T cellular cooperation, which
is necessary to induce antibodies against thymodependent antigens.
Thus, the four strains used in this study were able to generate
specific immune responses against the parasite S. mansoni. However, only DR-expressing mice were able to mount a protective response. Between the two DR alleles studied, the DR2 seems to be more
effective in our system. It should be noted that DR2.A
° mice
express a murine alpha chain I-E
k, which might influence
the efficiency of the interaction between MHC class II molecules and
the murine T-cell receptor. An epidemiological study implicating the
DR2 allele (15) showed that this allele might be linked to
resistance to severe forms of schistosomiasis, but this finding was not
confirmed by others (34). It is difficult to compare our
results to those of epidemiological studies since the mechanisms
implicated in the initial stage of granuloma induction and those
effective in the chronic stages are different. Nevertheless, it is
interesting to mention that Geluk et al. (13), using DR3 transgenic mice, identified the same immunodominant determinants to
hsp65 (heat shock protein) of Mycobacterium tuberculosis as those recognized by DR3 human T cells. Unfortunately, we could not
acquire mice expressing HLA-DQB1*0201, an allele which was associated
with an increased risk in developing severe hepatosplenic forms of
schistosomiasis (34).
It is known that DRB1 are the main MHC class II molecules expressed on cells (representing about 40 to 50%), while DQ molecules are represented in lower amounts (about 15 to 20% of the pool). Accordingly, it is tempting to conclude that the induction of the immune response observed in schistosomiasis (i.e., a granulomatous reaction) is mainly due to DR responses, while DQ molecules are less effective. However, the relative effect of HLA-DR versus HLA-DQ interactions should further be investigated. Based on the finding that DQ6 is transmitted cross-linked with DR2, it would be interesting to study the consequences of S. mansoni infection in double transgenic mice in order to establish whether DQ6 molecules are ineffective in presenting schistosomal antigens.
In conclusion, all of the four strains used in this study: DR1.A
°,
DR2.A
°, DQ8.A
°, and DQ6.A
° mice were able to generate specific immune response against S. mansoni antigens,
although with some quantitative and qualitative differences. Mice
expressing the DR alleles (DR1 and DR2) showed effective granulomas,
surviving until the chronic stage of infection and mounting cellular
reaction with predominant IFN-
production. In contrast, mouse
strains expressing DQ alleles showed an impairment in generating
granulomas, while mounting a lower specific immune response against the
parasite than had the DR mice. Thus, we conclude that DR alleles might play an important role in inducing the granulomatous response, whereas
DQ alleles seem to be less effective, reflecting the influence of HLA
polymorphism in the establishment of protective response. However, the
panel of alleles studied should be enlarged, and the relative
importance of each one of these alleles should be further investigated.
| |
ACKNOWLEDGMENTS |
|---|
This study was financially supported by CNRS, the Pasteur Institute of Lille, and the Région Nord-Pas de Calais (Ph.D. studentship to G.A.).
We are indebted to Chella S. David and Daniel Altmann for providing transgenic mice. We are also grateful to Julie Hanson and Michelle Smart for technical advice.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: UMR 8527 CNRS, Institut de Biologie, 1 rue du Professeur Calmette, BP447, F-59021 Lille, France. Phone: 33 (0) 3-20-87-12-47. Fax: 33 (0) 3-20-87-12-33. E-mail: gerhild.angyalosi{at}ibl.fr.
Editor: J. M. Mansfield
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Altmann, D.,
D. Douek,
A. Frater,
C. Hetherington,
H. Inoko, and J. Elliott.
1995.
The T cell response of HLA-DR transgenic mice to human basic protein and other antigens in the presence and absence of human CD4.
J. Exp. Med.
181:867-875 |
| 2. |
Amiri, P.,
R. Locksley,
T. Parslow,
M. Sadick,
E. Rector,
D. Ritter, and J. McKerrow.
1992.
Tumor necrosis factor restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice.
Nature
356:604-607[CrossRef][Medline].
|
| 3. |
Angyalosi, G.,
V. Pancré,
J. Herno, and C. Auriault.
1998.
Immunological response of major histocompatibility complex class II-deficient (A °) mice infected by the parasite Schistosoma mansoni.
Scand. J. Immunol.
48:159-169[CrossRef][Medline].
|
| 4. | Bradley, D., G. Nabozny, S. Cheng, P. Zhou, M. Griffiths, H. Luthra, and C. S. David. 1997. HLA-DQB1 polymorphism determines incidence, onset and severity of collagen-induced arthritis in transgenic mice. Implications in human rheumatoid arthritis. J. Clin. Investig. 100:2227-2234[Medline]. |
| 5. | Chandrasekharappa, S., R. M. Rebelsky, T. A. Firak, M. M. Le Beau, and C. A. Westbrook. 1990. A long-range map of the interleukin-4 and interleukin-5 linkage group on chromosome. Genomics 6:94-99[CrossRef][Medline]. |
| 6. | Chapoval, S. P., G. Nabozny, E. L. Marietta, E. L. Raymond, C. J. Krco, A. G. Andrews, and C. S. David. 1999. Short ragweed allergen induces eosinophilic lung disease in HLA-DQ transgenic mice. J. Clin. Investig. 103:1707-1717[Medline]. |
| 7. | Cheng, S., J. Baisch, C. Krco, S. Savarirayan, J. Hanson, K. Hodgson, M. Smart, and C. David. 1996. Expression and function of HLA-DQ8 (DQA1*0301/DQB1*0302) genes in transgenic mice. Eur. J. Immunogenet. 23:15-20[Medline]. |
| 8. | Cosgrove, D., D. Gray, A. Dierich, J. Kaufman, M. Lemeur, C. Benoist, and D. Mathis. 1991. Mice lacking MHC class II molecules. Cell 66:1051-1066[CrossRef][Medline]. |
| 9. |
Czaja, M.,
F. Weiner,
S. Takahashi,
M. Giambrone,
P. van der Meide,
H. Schellekens,
L. Biempica, and M. Zern.
1989.
-IFN treatment inhibits collagen deposition in murine schistosomiasis.
Hepatology
10:795-800[Medline].
|
| 10. | Dessein, A., D. Hillaire, N. E. Elwali, S. Marquet, Q. Mohammed-Ali, A. Mirghani, S. Henri, A. A. Abdelhameed, O. K. Saed, M. M. Magzoub, and L. Abel. 1999. Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene. Am. J. Hum. Genet. 65:709-721[CrossRef][Medline]. |
| 11. | Doenhoff, M. J., S. Pearson, D. W. Dunne, Q. Bickle, S. Lucas, J. Bain, R. Musallam, and O. Hassounah. 1981. Immunological control of hepatotoxicity and parasite egg excretion in S. mansoni infections: stage specificity of the reactivity of immune serum in T-cell-deprived mice. Trans. R. Soc. Trop. Med. Hyg. 75:41-53[CrossRef][Medline]. |
| 12. |
Fallon, P. G.,
E. J. Richarsdon,
G. J. McKenzie, and A. N. J. McKenzie.
2000.
Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent.
J. Immunol.
164:2585-2591 |
| 13. |
Geluk, A.,
V. Taneja,
K. E. van Meijgaarden,
E. Zanelli,
C. Abou-Zeid,
J. E. R. Thole,
R. R. P. de Vries,
C. S. David, and T. Ottenhoff.
1998.
Identification of HLA class II-restricted determinants of Mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice.
Proc. Natl. Acad. Sci. USA
95:10797-10802 |
| 14. | Gonzales-Gay, M. A., E. Zanelli, S. D. Khare, C. J. Krco, P. Zhou, H. Inoko, M. M. Griffiths, H. S. Luthra, and C. S. David. 1996. Human leukocyte antigen DRB1*1502 (DR2DW12) transgene reduces incidence and severity of arthritis in mice. Hum. Immunol. 50:54-60[CrossRef][Medline]. |
| 15. | Hafez, M., S. Aboul Hassan, H. el-Tahan, F. el-Shennawy, M. Khashaba, Y. al-Tonbary, Z. el-Morsi, S. el-Sallab, I. el-Desoky, and A. el-Shazly. 1991. Immunogenetic susceptibility for post-schistosomal hepatic fibrosis. Am. J. Trop. Med. Hyg. 44:424-433. |
| 16. | Kawamura, K., T. Yamamura, K. Yokoyama, D.-H. Chui, Y. Fukui, T. Sasazuki, H. Inoko, C. S. David, and T. Tabira. 2000. HLA-DR2-restricted responses to proteolipid protein 95-116 peptide cause autoimmune encephalitis in transgenic mice. J. Clin. Investig. 105:997-984. |
| 17. |
Kong, Y. C. M.,
L. Lomo,
R. Motte,
A. A. Giraldo,
J. Baisch,
G. Strauss,
G. J. Hammerling, and C. S. David.
1996.
HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene.
J. Exp. Med.
184:1167-1172 |
| 18. | Lopez-de Leon, A., and M. Rojkind. 1985. A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J. Histochem. Cytochem. 33:737-743[Abstract]. |
| 19. |
Lortat-Jacob, H.,
F. Baltzer,
A. Desmoulière,
S. Peyrol, and J.-A. Grimaud.
1997.
Lobular but not periovular-inhibition of collagen deposition in the liver of S. mansoni-infected mice using interferon-gamma.
J. Hepatol.
26:894-903[CrossRef][Medline].
|
| 20. | Markowitz, J. S., P. R. Rogers, M. J. Grusby, D. C. Parker, and L. H. Glimcher. 1993. B lymphocyte development and activation independent of MHC class II expression. J. Immunol. 150:1223-1233[Abstract]. |
| 21. | Marquet, S., L. Abel, D. Hillaire, H. Dessein, and A. Dessein. 1999. Full results of the genome-wide scan which localises a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Eur. J. Hum. Genet. 7:88-97[CrossRef][Medline]. |
| 22. | Marquet, S., L. Abel, D. Hillaire, H. Dessein, J. Kalil, J. Feingold, J. Weissenbach, and A. Dessein. 1996. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat. Genet. 14:181-184[CrossRef][Medline]. |
| 23. |
Mathew, R., and D. Boros.
1986.
Anti-L3T4 antibody treatment suppresses hepatic granuloma formation and abrogates antigen-induced interleukin 2 production in Schistosoma mansoni infection.
Infect. Immun.
54:820-826 |
| 24. | Neeno, T., C. Krco, J. Harders, J. Baisch, S. Cheng, and C. David. 1996. HLA-DQ8 transgenic mice lacking endogenous class II molecules respond to house dust allergens. J. Immunol. 156:3191-3195[Abstract]. |
| 25. | Ottenhoff, T. H. M., J. B. A. G. Haanen, A. Geluk, T. Mutis, A. B. Kale, J. E. R. Thole, W. C. A. van Shooten, P. J. van den Elsen, and R. R. P. de Vries. 1991. Regulation of mycobacterial heat-shock protein reactive T cells by HLA class II molecules: lessons from leprosy. Immunol. Rev. 121:171-191[CrossRef][Medline]. |
| 26. |
Pancré, V.,
I. Wolowczuk,
S. Guerret,
M. Copin,
A. Delanoye,
A. Capron, and C. Auriault.
1994.
Protective effect of Sm28GST-specific T cells in schistosomiasis: role of gamma interferon.
Infect. Immun.
62:3723-3730 |
| 27. |
Pearce, E.,
S. James,
J. Dalton,
A. Barrall,
C. Ramos,
M. Strand, and A. Sher.
1991.
Down regulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni.
J. Exp. Med.
173:159-166 |
| 28. |
Phillips, S.,
J. DiConza,
J. Gold, and W. Reid.
1977.
Schistosomiasis in the congenitally athymic (nude) mouse. I. Thymic dependency of eosinophilia, granuloma formation, and host morbidity.
J. Immunol.
118:594-599 |
| 29. | Raju, R., S. Munn, and C. S. David. 1997. T cell recognition of human pre-proinsulin peptides depends on the polymorphism at HLA DQ locus: a study using HLA DQ8 and DQ6 transgenic mice. Hum. Immunol. 1997:21-29. |
| 30. | Ramalho-Pinto, G., G. Gazzinelli, R. E. Howells, T. A. Mota-Santos, E. A. Figueiredo, and J. Pellegrino. 1974. Schistosoma mansoni: defined system for stepwise transformation of cercariae to schistosomula in vitro. J. Exp. Parasitol. 36:360. |
| 31. | Remoue, F., F. Rogerie, M.-C. Gallisot, H. L. Guyatt, J.-L. Neyrinck, M.-M. Diakkhate, M. Niang, A. E. Butterworth, C. Auriault, A. Capron, and G. Riveau. 2000. Sex-dependent neutralizing humoral response to Schistosoma mansoni 28GST antigen in infected human populations. J. Infect. Dis. 181:1855-1859[CrossRef][Medline]. |
| 32. |
Salam, E. A.,
S. Ishaac, and A. A. F. Mahmoud.
1979.
Histocompatibility-linked susceptibility for hepatosplenomegaly in human schistosomiasis mansoni.
J. Immunol.
123:1829-1831 |
| 33. | Saltman, D. L., G. Dolganov, J. A. Warrington, J. J. Wasmuth, and M. A. Lovett. 1990. A physical map of 15 loci on human chromosome 5q23-q33 by two-color fluorescence in situ hybridization. Genomics 16:726-732. |
| 34. | Secor, E., H. del Corral, M. dos Reis, E. A. Ramos, A. E. Zimon, E. Peixoto Matos, E. A. G. Reis, T. M. A. do Carmo, K. Hirayama, R. A. David, J. R. David, and D. A. Harn. 1996. Association of hepatosplenic schistosomiasis with HLA-DQB1*0201. J. Infect. Dis. 174:1131-1135[Medline]. |
| 35. | Smithers, S. R., and R. J. Terry. 1969. The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms. Parasitology 55:695-700. |
| 36. | Taneja, V., and C. S. David. 1999. HLA class II transgenic mice as models of human diseases. Immunol. Rev. 169:67-79[CrossRef][Medline]. |
| 37. | Warren, K. S., E. O. Domingo, and R. B. T. Cowan. 1967. Granuloma formation around schistosome eggs as a manifestation of delayed hypersensitivity. Am. J. Pathol. 51:735-756[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|